D. E. Shaw & Co., Inc. - TONIX PHARMACEUTICALS HLDG C ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$1,153,000
-82.7%
5,009,843
-73.2%
0.00%
-83.3%
Q4 2021$6,682,000
+66.1%
18,680,699
+179.2%
0.01%
+50.0%
Q3 2021$4,022,000
+382.3%
6,690,867
+790.6%
0.00%
+300.0%
Q2 2021$834,000751,2970.00%
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q3 2023.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders